HOME BASED TREATMENT
Dr. McCollough Explains Protocols
by Luis B. Vega
for PostScripts News (PSN) | www.PostScripts.org
‘When it comes to advise for the country, there has been an approach of giving no hope, no window for Treatment. No advise on Treatments, nothing. It is almost as if there is a promotion of as much suffering, despair, anxiety, hospitalization, and death as possible in preparation for Mass Vaccinations.’ – Dr. Peter McCullough interview with Robert F. Kennedy Jr.
The following is the Home Guide to treat COVID-19 at the first early stages and/or days. This was provided by a Dr. Peter McCullough of Dallas, Texas. His initial Home Based Treatment of COVID-19 were posted to YouTube but were later banned. Ironically, he and his wife tested positive for COVID-19 and administered the home remedy treatment on themselves with success and highly recommend it to treat the early symptoms of COVID-19 and subsequent lapse time of the recovery.
The Doctor mentioned that early detection and Treatment are the key to full recovery because as he put it, if a Patient ends-up needing Oxygen, by that time there is a 12% of death. Then if a Patient ends up in the ICU, hospitalized, there is a 22-34% chance of certain death. His concern is that Doctors, Scientists and the Governments have purposely refused to invest time and energy into such preventative Treatments, at least in the USA. Dr. McCullough is a big proponent of finding and using Treatments already proven to treat COVID-19. The links to the presentation are in the endnotes. The following list is what he recommends as not all Health Care Providers Treat COVID-19.
COVID-19 Home Based Instruments
Recommend instruments to have at home for Tele-Appointments with Doctors.
2. Pulse Meter (Oximeter)
3. Blood Pressure Monitor
COVID-19 Home Based Treatment Mediations
Recommended to have in home for Treating early symptoms of COVID-19.
1. Aspirin (ASA)
-Taken at 325 ml/day.
2. Zinc/Vitamin D3/Vitamin C (Zn/D3/C)
-Taken at ~220 mg/day for Zinc and 3k mg/day for D3/C.
-These protect the Tissues and prevent rapid spread of virus.
3. Ivermectin (IVM)
-It is a broad Anti-Parasitic Agent.
-Helps reduce the ability of the virus from entering the Cell Nucleus.
-Taken at 3 mg/day – Single dose.
4. Hydroxychloroquine (HCQ)
-Used for treating Malaria for decades and Lupus, Rheumatoid Arthritis.
-Helps reduce transmission of virus from cell to cell.
-If administered early on, has an 80% recovery rate on Patients.
-Found to not be effective in advanced stages such as in ICU hospitalizations.
5. Azithromycin (AZM)
-It is a Micro-Light Antibody with a mild Anti-Viral Property.
-Helps reduce 2nd contributing factors
-Due to bacteria forming in the Trachea-Bronchial Tree.
-Taken at 250 mg/day twice a day.
6. Doxycycline (DOXY)
-This can be taken instead of Azithromycin (AZM).
-As a Base Treatment.
6. If wheezing,
-60mg/day for 5 days to ease constriction in the lungs.
The following is the portion of Dr. McCullough’s Vitae and contact information. He does do Tele-Appointments for Patients.
PETER A. McCullough,
MD, MPH, FACP, FACC, FCCP, FAHA, FNKF, FNLA, FCRSA
ABOUT DR. McCullough:
Dr. McCullough is Board Certified in Internal Medicine, Cardiovascular Diseases, and Clinical Lipidology. He cares for Advanced Patients with common medical problems including Heart and Kidney Disease, Lipid Disorders, and Diabetes. He has become an expert on COVID-19 illnesses and welcomes Recovered Patients into his Practice.
After receiving a Bachelor’s Degree from Baylor University, Dr. McCullough completed his Medical Degree as an Alpha Omega Alpha graduate from the University of Texas Southwestern Medical School. He went on to complete his Internal Medicine Residency at the University of Washington, Cardiology Fellowship including service as Chief Fellow at William Beaumont Hospital.
He completed his Master’s Degree in Public Health at the University of Michigan. Dr. McCullough is a practicing Internist and Cardiologist and Professor of Medicine at Texas A & M College of Medicine. Dr. McCullough has broadly published on a range of topics in medicine with >1000 publications and >600 citations in the National Library of Medicine. His works include the ‘Interface between Renal Disease and Cardiovascular Illness’ in Braunwald’s Heart Disease Textbook. Dr. McCullough is a Founder and current President of the Cardiorenal Society of America, an organization dedicated to bringing Cardiologists and Nephrologists together to work on the emerging problem of Cardiorenal Syndromes. His works have appeared in the New England Journal of Medicine, Journal of the American Medical Association, Lancet, British Medical Journal and other top-tier journals worldwide.
He is the Editor-In-Chief of Cardiorenal Medicine, Reviews in Cardiovascular Medicine, and Senior Associate editor of the American Journal of Cardiology. He serves on the editorial boards of multiple specialty journals. Dr. McCullough has made presentations on the advancement of medicine across the world and has been an invited lecturer at the New York Academy of Sciences, the National Institutes of Health, U.S. Food and Drug Administration (FDA), and the European Medicines Agency. He has served as Member or Chair of Data Safety Monitoring Boards of 24 randomized clinical trials.
Since the outset of the pandemic, Dr. McCullough has been a leader in the medical response to the COVID-19 disaster and has published ‘Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection’ the first synthesis of sequenced multidrug treatment of ambulatory Patients infected with SARS-CoV-2 in the American Journal of Medicine and subsequently updated in Reviews in Cardiovascular Medicine.
He has 35 peer-reviewed publications on the Infection and has commented extensively on the Medical Response to the COVID-19 crisis in The Hill. On November 19, 2020, Dr. McCullough testified in the US Senate Committee on Homeland Security and Governmental Affairs concerning early ambulatory treatment of High-Risk Patients with COVID-19. Dr. McCullough is a COVID-19 Survivor himself and welcomes post-COVID-19 patients into his Practice and will help them through the range of Post-Infection Complications.
Baylor Scott & White Heart and Vascular Hospital - Dallas * Fort Worth
Baylor University Medical Center
Baylor Heart & Vascular Hospital-BHVH
Office: (214) 841-2000
Fax: (844) 292-1458
3409 Worth Street
Dallas, TX 75246
Graduate: Certificate of Graduate Liberal Arts Studies: Southern Methodist University (2016)
Fellowship, Cardiovascular Disease: William Beaumont Hospital (presently Oakland University William Beaumont School of Medicine), Royal Oak, MI (1997)
Chief Cardiovascular Fellow: William Beaumont Hospital (presently Oakland University William Beaumont School of Medicine), Royal Oak, MI (1996-1997)
Graduate: Master of Public Health/General Epidemiology, University of Michigan School of Public Health (1994)
Internship/Residency, Internal Medicine: University of Washington School of Medicine, Seattle, WA (1991)
Medical School, MD Degree: University of Texas Southwestern Medical School, Dallas, TX (1988)
Undergraduate (honors): Bachelor of Science: Biology and Psychology, Baylor University, Waco, TX (1984)
Internist, Cardiologist, Baylor Heart and Vascular Hospital, Baylor University Medical Center, Professor of Medicine - Texas A&M University College of Medicine, Dallas Campus (2014-present)
Chief Academic and Scientific Officer (Academic Dean Equivalent) - St. John Providence Health System, (2010-2013)
Division Chief, Nutrition and Preventive Medicine, Medical Director, Preventive Cardiology - Oakland University William Beaumont School of Medicine (2002-2010)
Associate Professor of Medicine/Cardiology Section Chief - University of Missouri-Kansas City School of Medicine (2000-2002)
Assistant Professor of Medicine, Program Director in Cardiology, Henry Ford Hospital (1997-2000)
© Published by Vegapost Publications
A website dedicated to the study of Biblical Eschatology.
This is PostScripts News Article #457.
Read more Articles at: www.PostScripts.org/articles.html
Follow PSN online at www.PostScripts.org